Skip to main content

Advertisement

Log in

Combination therapy with cyclosporine A and anti-TNF-α agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

We describe two cases of rheumatoid arthritis (RA) patients and concomitant hepatitis C virus infection (HCV), treated with cyclosporine A (CsA) and anti-TNF-α agents. SGOT/SGPT and HCV-RNA serum levels remained unchanged longer than 1 year of treatment. No side effects were registered. We suggest that combination therapy with CsA and TNF-α blockers should be considered safe and well-tolerated in the treatment of HCV-positive RA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, Marotta P, Boillot O, Muehlbacher F, Klintman G; LIS2T Study Group (2004) Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplant Proc 77:1632–1638

    Article  PubMed  CAS  Google Scholar 

  2. Casanovas Taltavull T (2004) Impact of Cyclosporine on the development of immunosuppressive therapy in liver transplantation. Transplant Proc 36:S291–S294

    Article  Google Scholar 

  3. Nakamuta M, Kohjima M, Fukushima M, Morizono S, Kotoh K, Kobayashi N, Enjoji M (2005) Cyclosporine suppresses cell growth and collagen production in hepatic stellate cells. Transplant Proc 37:4598–4602

    Article  PubMed  CAS  Google Scholar 

  4. Inoue K, Sekiyama K, Yamada M, Watanabe T, Yasuda H, Yoshiba M (2003) Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol 38:567–572

    PubMed  CAS  Google Scholar 

  5. Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K (2003) Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 38:1282–1288

    Article  PubMed  CAS  Google Scholar 

  6. Galeazzi M, Bellisai F, Manganelli S, Morozzi G, Sebastiani GD (2006) Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. Autoimmun Rev 5(7):493–498

    Article  PubMed  CAS  Google Scholar 

  7. Ellerin T, Rubin RH, Weinblatt ME (2003) Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 48:3013–3022

    Article  PubMed  CAS  Google Scholar 

  8. Peterson JR, Hsu FC, Simkin PA, Wener MH (2003) Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 62:1078–1082

    Article  PubMed  CAS  Google Scholar 

  9. Duvoux C, Mennecier D, Pageaux G (2002) Immunosuppression with tacrolimus and absence of antihypertensive therapy are associated with fibrosis progression after hepatitis C virus graft reinfection. In: International Society of Transplantation Congress, abstract no. 2652

  10. McCaughan GW (2004) Immunosuppression for HCV following liver transplantation: enough is just enough. Transplantation 78:1413–1414

    Article  PubMed  CAS  Google Scholar 

  11. Nakagawa M, Sakamoto N, Tanabe Y, Koyama T, Itsui Y, Takeda Y, Chen CH, Kakinuma S, Oooka S, Maekawa S, Enomoto N, Watanabe M (2005) Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins. Gastroenterology 129:1031–1041

    Article  PubMed  CAS  Google Scholar 

  12. Miura H, Itoh Y, Matsumoto Y, Tani M, Tanabe N, Isonokami M, Kurachi K, Kozuka T (1999) Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases. Int J Dermatol 38:310–314

    Article  PubMed  CAS  Google Scholar 

  13. Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, Singer MV, Rossol S (1998) Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 111:269–277

    Article  PubMed  CAS  Google Scholar 

  14. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY (1997) Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 42:2487–2494

    Article  PubMed  CAS  Google Scholar 

  15. Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N, Nogami C, Miyake T, Niigaki M, Tokuda A, Satoh S, Sakai S, Akagi S, Watanabe M, Fukumoto S (1996) Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 16:390–399

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mauro Galeazzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellisai, F., Giannitti, C., Donvito, A. et al. Combination therapy with cyclosporine A and anti-TNF-α agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection. Clin Rheumatol 26, 1127–1129 (2007). https://doi.org/10.1007/s10067-006-0412-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0412-1

Keywords

Navigation